Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
17,120
Total Claims
$1.2M
Drug Cost
667
Beneficiaries
$1,796
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-73%
Opioid rate vs peers
0.7% vs 2.6% avg
+68%
Cost per patient vs peers
$1,796 vs $1,068 avg
+135%
Brand preference vs peers
21.1% vs 9.0% avg
Opioid Prescribing
0.7%
Opioid Rate
121
Opioid Claims
$4,000
Opioid Cost
16.5%
Long-Acting Rate
Brand vs Generic
Brand: 3,613 claims · $864K
Generic: 13,476 claims · $329K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 892 | $238K |
| Sitagliptin Phosphate | 169 | $49K |
| Rifaximin | 35 | $45K |
| Rivaroxaban | 132 | $33K |
| Empagliflozin | 116 | $31K |
| Voriconazole | 26 | $25K |
| Sacubitril/Valsartan | 72 | $22K |
| Ipratropium/Albuterol Sulfate | 44 | $22K |
| Dextromethorphan Hbr/Quinidine | 27 | $19K |
| Tiotropium Bromide | 34 | $18K |
| Linagliptin | 67 | $17K |
| Tenofovir Alafenamide | 11 | $16K |
| Dulaglutide | 34 | $16K |
| Insulin Lispro | 122 | $15K |
| Atorvastatin Calcium | 1,117 | $15K |
Prescribing Profile
Patient Profile
80
Avg Age
56%
Female
2.90
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data